abstract |
FIELD: medicine, pharmaceutics. n SUBSTANCE: present invention refers to a method for reducing the blood uric acid concentration involving administering a compound of formula I or a pharmaceutically acceptable salts thereof. Besides, the present invention refers to a method of treating preventing a number of conditions, including uratic arthritis, hyperuricemia, the uric acid levels exceeding those normally diagnosed as hyperuricemia. n EFFECT: declared compound of formula I may be used in the pharmaceutical composition. n 22 cl, 6 dwg, 13 tbl, 28 ex |